Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis

被引：6

作者：

Zhou, Xueyin ^{[1
,2
]}

Cao, Jiasheng ^{[2
,3
]}

Topatana, Win ^{[3
]}

Xie, Tianao ^{[4
]}

Chen, Tianen ^{[2
,3
]}

Hu, Jiahao ^{[2
,3
]}

Li, Shijie ^{[2
,3
]}

Juengpanic, Sarun ^{[3
]}

Lu, Ziyi ^{[3
,5
]}

Zhang, Bin ^{[2
,3
]}

Wang, Kaitai ^{[1
]}

Feng, Xu ^{[2
,3
]}

Shen, Jiliang ^{[2
,3
]}

Chen, Mingyu ^{[2
,3
]}

机构：

[1] Wenzhou Med Univ, Sch Med, Wenzhou 325035, Zhejiang, Peoples R China

[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gen Surg, Hangzhou 310016, Zhejiang, Peoples R China

[3] Zhejiang Univ, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China

[4] Guangzhou Med Univ, Clin Sch 3, Dept Clin Med, Guangzhou 511436, Peoples R China

[5] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Peoples R China

来源：

IMMUNOTHERAPY | 2023年 / 15卷 / 05期

关键词：

biomarker; hepatocellular carcinoma; meta-analysis; PD-L1; systematic review; UROTHELIAL CARCINOMA; EXPRESSION; ATEZOLIZUMAB; MULTICENTER;

D O I：

10.2217/imt-2022-0168

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Aim:To determine if PD-L1 can be used as a biomarker to predict the efficacy of anti-PD-1/PD-L1 inhibitors in hepatocellular carcinoma (HCC). Methods:Relevant studies from a specific search of the four databases from October 2014 to December 2022 were included in this meta-analysis. Results:Higher PD-L1 expression levels were associated with a higher objective response rate (ORR). Higher PD-L1 expression levels on tumor cells and tumor proportion score were associated with higher ORR. PD-L1 was capable of predicting the effectiveness of nivolumab. Dako 28-8 is a promising assay for HCC. Conclusion:PD-L1 is a predictive biomarker for ORR in HCC. Tumor proportion score and PD-L1 expression levels on tumor cells are potential scoring algorithms.

引用

下载

页码：353 / 365

页数：13

共 50 条

[31] Smoking status-based efficacy difference in anti-PD-1/PD-L1 immunotherapy: a systematic review and meta-analysis
Nie, Run-Cong
Duan, Shu-Qiang YuanJin-Ling
Liang, Yao
Chen, Xiao-Jiang
Chen, Yong-Ming
Luo, Tian-Qi
Chen, Guo-Ming
Wang, Yun
Li, Yuan-Fang
IMMUNOTHERAPY, 2020, 12 (18) : 1313 - 1324
[32] Prognostic role of PD-L1 expression in patients with salivary gland carcinoma: A systematic review and meta-analysis
Wu, Limeng
Jiang, Canhua
Zhu, Zhihui
Sun, Yao
Zhang, Tao
PLOS ONE, 2022, 17 (07):
[33] Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis
Roberto Iacovelli
Franco Nolè
Elena Verri
Giuseppe Renne
Chiara Paglino
Matteo Santoni
Maria Cossu Rocca
Palma Giglione
Gaetano Aurilio
Daniela Cullurà
Stefano Cascinu
Camillo Porta
Targeted Oncology, 2016, 11 : 143 - 148
[34] Prognostic role of PD-L1 expression in renal cell carcinoma (RCC): A systematic review and meta-analysis
Nole, F.
Aurilio, G.
Iacovelli, R.
Paglino, C.
Cullura, D.
Giglione, P.
Verri, E.
Rocca, M. Cossu
Renne, G.
Porta, C.
EUROPEAN JOURNAL OF CANCER, 2015, 51 : S530 - S530
[35] Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis
Iacovelli, Roberto
Nole, Franco
Verri, Elena
Renne, Giuseppe
Paglino, Chiara
Santoni, Matteo
Rocca, Maria Cossu
Giglione, Palma
Aurilio, Gaetano
Cullura, Daniela
Cascinu, Stefano
Porta, Camillo
TARGETED ONCOLOGY, 2016, 11 (02) : 143 - 148
[36] Efficacy and safety of PD-1/PD-L1 inhibitors in patients with Merkel Cell Carcinoma: a systematic review and Meta-analysis
Francisco Cezar Aquino de Moraes
Michele Kreuz
Isabella Christina Amaral de Lara
Artur de Oliveira Macena Lôbo
Rommel Mario Rodríguez Burbano
BMC Cancer, 24 (1)
[37] PD-L1 is associated with the prognosis of penile cancer: A systematic review and meta-analysis
Lu, Yi
Wang, Yutao
Su, Hao
Li, Hongjun
FRONTIERS IN ONCOLOGY, 2022, 12
[38] PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis
Gandini, Sara
Massi, Daniela
Mandala, Mario
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 100 : 88 - 98
[39] Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
Ding, Ziniu
Dong, Zhaoru
Chen, Zhiqiang
Hong, Jianguo
Yan, Lunjie
Li, Haichao
Yao, Shengyu
Yan, Yuchuan
Yang, Yafei
Yang, Chuncheng
Li, Tao
FRONTIERS IN IMMUNOLOGY, 2021, 12
[40] Efficacy and Safety of PD-1/PD-L1 Inhibitor as Single-Agent Immunotherapy in Endometrial Cancer: A Systematic Review and Meta-Analysis
Yusof, Mohd Nazzary
Chew, Kah Teik
Hafizz, Abdul Muzhill Hannaan Abdul
Abd Azman, Siti Hajar
Ab Razak, Wira Sofran
Hamizan, Muhammad Rafi'uddin
Kampan, Nirmala Chandralega
Shafiee, Mohamad Nasir
CANCERS, 2023, 15 (16)

← 1 2 3 4 5 →